CSF1R and colitis: This is likely tied to the biology of monocyte recruitment from the blood to the gut both in healthy and inflamed settings, suggesting that systemic CSF1R inhibition is required to elicit full colon macrophage depletion and colitis disease reduction, and perhaps CSF1R was not an ideal target to test proof-of-concept for gut-delivery strategies.